Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
09/2006
09/21/2006US20060212948 constructing a nucleus-implanted egg produced from maternal genomes alone and having 2 haploid genome sets derived from mammal ova and is able to grow up to adulthood
09/21/2006US20060212947 Non-naturally occurring animal that expresses an untranslated non-coding RNA
09/21/2006US20060211116 Transposase and method of gene modification
09/21/2006US20060211113 Method and system for introducing a gene into a human stem cell
09/21/2006CA2601677A1 Gene disruptions, compositions and methods relating thereto
09/20/2006EP1702620A1 Immunopotentiator and method of enhancing immunological activity with the same
09/20/2006EP1702061A1 A method for isolating a self-renewing, multipotent slow-cycling cell
09/20/2006EP1701613A1 A procedure for screening of neuroactive substance and the associated neural plasticity
09/20/2006EP1701612A2 Chimeric murine model comprising human hepatocytes user for screening compounds
09/20/2006EP1701611A1 Transgenic non-human mammal comprising a polynucleotide encoding human or humanized c5ar
09/20/2006EP1356025B1 Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene
09/20/2006EP1095165B1 Method for identifying mutants and molecules
09/20/2006CN2817424Y Planktont counting frame
09/20/2006CN1835679A Process for producing human-origin immunocompetent cell
09/20/2006CN1276080C Method for fish gene in site modification breeding
09/20/2006CN1275538C Soil-less breeding feed stuff and method for snail
09/20/2006CN1275517C Automatic silkworm egg counting method and device based on digital image processing
09/19/2006US7109027 Aβ-Peptide screening assay
09/19/2006US7108989 Therapy
09/14/2006WO2006096648A2 Mouse model
09/14/2006WO2006095846A1 Model animal in which state of disease condition is observable in real time, gene construct for achieving the same and use of the same
09/14/2006WO2006094703A1 Use of an antagonist of epac for treating human cardiac hypertrophy
09/14/2006WO2006094363A1 Processing pedigree data
09/14/2006WO2006047311A3 Cloning of the retinoic acid inducible gene-1 promoter and uses thereof
09/14/2006WO2006023210A3 Gp132: mehods and compositions for treating cancer
09/14/2006WO2006020949A3 Combined gene therapy for the treatment of macroscopic gliomas
09/14/2006WO2006020184A3 Retinal dystrophin transgene and methods of use thereof
09/14/2006WO2006008484A3 Detection of cellular stress
09/14/2006WO2005115136A3 Transgenic models of alzheimer’s disease and uses thereof in the treatment of a variety of neurodegenerative diseases
09/14/2006WO2005103694A3 Methods and fish models for identifying agents for treating bone and joint disease
09/14/2006US20060206952 Transgenic chickens
09/14/2006US20060206951 GABA B1A receptor disruptions, compositions and methods relating thereto
09/14/2006US20060206950 In vivo imaging of e2f-fegulated bioluminescent proteins
09/14/2006US20060206949 Custom-made meganuclease and use thereof
09/14/2006US20060206948 C-Reactive Protein (CRP); peptide biodrugs used to reduce body weight, adiposity, and alleviate insulin resistance and diabetes
09/14/2006US20060206947 Heterodimeric protein binding compositions
09/14/2006US20060206946 Method of disrupting heme transport in nematodes and of modelling and evaluating eukaryotic heme transport
09/14/2006US20060205077 Targeted transgenesis using the rosa26 locus
09/14/2006US20060205021 Mammalian IAP gene family, primers, probes and detection methods
09/14/2006US20060201429 Method of producing avian eggs and birds of germ-free status
09/14/2006CA2599783A1 Use of an antagonist of epac for treating human cardiac hypertrophy
09/14/2006CA2599751A1 Processing pedigree data
09/14/2006CA2599577A1 Nucleic acids and proteins and methods for making and using them
09/13/2006EP1700914A1 Development of mammalian genome modification technique using retrotransposon
09/13/2006EP1699289A1 Non-human mammal comprising a modified serca2 gene and methods, cells, genes, and vectors thereof
09/13/2006EP1499180A4 Cancer models
09/13/2006EP1339840B1 Schizophrenia-related voltage-gated ion channel gene and protein
09/13/2006EP1196579B1 Tryptase inhibitor
09/13/2006EP1088084B1 Erythropoietin analog-human serum albumin fusion protein
09/13/2006CN1830245A Technology of industrial production of syrphid eating cecidomyiia
09/13/2006CN1274822C Method for chemically inducing gynogenesis of living fishes
09/13/2006CN1274814C Method for raising efficiency for producing transgenic animal
09/13/2006CN1274375C High energy array magnetic core of biological magnetic field regulation
09/13/2006CN1274210C Method for producing colorful silk using silkworm
09/12/2006US7105717 Introduced with an SV 40 large T antigen gene under the control of probasin gene promoter; particularly related to the PBSVT transgenic rat 2971 lines; screening for a substance promoting the onset and/or progress of, or suppressing the onset and/or progress of prostate cancer
09/12/2006US7105652 Human tumor suppressor gene
09/12/2006US7105650 Nucleotide sequences which code binding protein for use in taste simulation and food processing
09/12/2006US7105484 GDNF receptorα
09/12/2006US7105348 Obtaining a large cloned genomic fragment; using bacterial homologous recombination to genetically modify to create a large targeting vector for use in eukaryotic cells (LTVEC); introducing LTVEC into eukaryotic cells; quantitative assay
09/12/2006US7105344 Fluorescent proteins as cell-type specific reporters
09/12/2006US7105333 Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon
09/08/2006WO2006093143A1 Model for nash or liver tumor, method for production of the model, method for screening of therapeutic agent for nash or liver tumor, method for analysis of mechanism for development of nash or liver tumorm, and agent for prevention or treatment of nash
09/08/2006WO2006092515A1 Transgenic mice and use thereof as an experimental model
09/08/2006WO2005025517A3 Animal model for protease activity and liver damage
09/08/2006CA2600912A1 Transgenic mice and use thereof as an experimental model
09/08/2006CA2575611A1 Covalent tethering of functional groups to proteins and substrates therefor
09/07/2006US20060200871 Transgenic non-human animals with expanded mature b cell and plasma cell populations
09/07/2006US20060200870 Methods of treating muscular dystrophy
09/07/2006US20060200869 Lentiviral vectors carrying synthetic bi-directional promoters and uses thereof
09/07/2006US20060199195 Nucleic acid encoding Schwannomin-Binding-Proteins and products related thereto
09/07/2006DE202005005194U9 Formicarium als Durchgangsbecken zur Haltung von Ameisen und anderen Kleintieren Formicarium as through pools for keeping ants and other small animals
09/06/2006EP1698693A1 Royal jelly peptide and composition containing the same
09/06/2006EP1698639A2 Pluripotency determining factors and uses thereof
09/06/2006EP1153543B1 Animals which are deficient in expressing uridine-phosphorylase
09/06/2006CN1829732A Imageable animal model of SARS infection
09/06/2006CN1826885A Method for prolonging development duration of yellow meal worm
09/06/2006CN1826884A Ecological method for transporting high-density earthworm
09/06/2006CN1826883A Method for transporting live larva of yellow meal worm
09/06/2006CN1273605C 蛋白质生产系统 Protein Production System
09/06/2006CN1273013C Method for breeding telenomus B. madarina using dissected egg of punctatus
09/06/2006CN1273012C Method for extracting natural hirudin from live body of Hirudinariamanillensis
09/05/2006USRE39270 infecting insect larvae with a baculovirus vector of a DNA encoding the protein of interest linked to a gene encoding a green fluorescent protein; fusion protein is expressed; measuring GFT fluorescence
09/05/2006US7101973 β-amyloid peptide-binding proteins and polynucleotides encoding the same
09/05/2006US7101971 Erythropoietin analog-human serum albumin fusion
09/05/2006US7101708 Hematopoietic cell composition for use in transplantation
09/05/2006US7101559 Immunomodulatory protein and useful embodiments thereof
09/03/2006CA2538465A1 System and method for inducing controlled cardiac damage
08/2006
08/31/2006WO2006091871A1 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
08/31/2006WO2006090918A1 Diabetes model animal
08/31/2006WO2006090724A1 Transgenic mouse or transgenic rat having mutant trpv3 gene introduced therein
08/31/2006WO2006090679A1 METHOD FOR DETECTION OF DNA DAMAGE USING Frag1 GENE OR GENE PRODUCT THEREOF AS MARKER
08/31/2006WO2006089910A1 Transgenic animal as a model for fibrotic diseases
08/31/2006WO2006065975A3 Methods of treating ankylosing spondylitis using anti-tnf antibodies and peptides of human tumor necrosis factor
08/31/2006WO2006040574A3 Lipocalin protein
08/31/2006US20060195918 reporter constructs for stem cell pluripotency and differentiation; bacterial artificial chromosome
08/31/2006US20060195917 Non-mammalian transgenic animal having an adult onset neurodegenerative phenotype
08/31/2006US20060195916 Mouse model for identifying modulators for treatment of lung scleroderma and pulmonary fibrosis
08/31/2006US20060195915 mesencephalic astrocyte-derived neurotrophic factor polypeptide; shown to protect the survival of embryonic mesencephalic dopaminergic neurons in culture
08/31/2006US20060194286 Apo-2LI and Apo-3 polypeptides
08/31/2006CA2599182A1 Regulators of protein misfolding and aggregation and methods of using the same